CYP2C9 allelic variants: ethnic distribution and functional significance (Q28212029)

Europe PubMed Central

title

CYP2C9 allelic variants: ethnic distribution and functional significance (English)

0 references

author name string

Hong-Guang Xie

1

0 references

Harish C Prasad

2

0 references

Richard B Kim

3

0 references

C Michael Stein

Advanced Drug Delivery Reviews

4

0 references

language of work or name

English

0 references

publication date

18 November 2002

0 references

published in

0 references

volume

54

0 references

issue

10

0 references

page(s)

1257-70

0 references

cites work

Human cytochrome P450 enzymes: a status report summarizing their reactions, substrates, inducers, and inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900076-5

7 January 2021

P450 superfamily: update on new sequences, gene mapping, accession numbers and nomenclature.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900076-5

7 January 2021

Relationship between CYP2C9 and 2C19 genotypes and tolbutamide methyl hydroxylation and S-mephenytoin 4'-hydroxylation activities in livers of Japanese and Caucasian populations

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900076-5

7 January 2021

Biochemistry and molecular biology of the human CYP2C subfamily

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900076-5

7 January 2021

Cytochrome P4502C9: an enzyme of major importance in human drug metabolism

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900076-5

7 January 2021

Phenotyping of drug-metabolizing enzymes in adults: a review of in-vivo cytochrome P450 phenotyping probes

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900076-5

7 January 2021

A 2.4-megabase physical map spanning the CYP2C gene cluster on chromosome 10q24

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900076-5

7 January 2021

Gene structure and upstream regulatory regions of human CYP2C9 and CYP2C18

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900076-5

7 January 2021

Cloning and expression of complementary DNAs for multiple members of the human cytochrome P450IIC subfamily

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900076-5

7 January 2021

Genetic polymorphisms and functional characterization of the 5'-flanking region of the human CYP2C9 gene: in vitro and in vivo studies

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900076-5

7 January 2021

Identification of a novel transcriptional silencer in the protein-coding region of the human CYP2C9 gene

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900076-5

7 January 2021

Transcriptional regulation of human CYP2C genes: functional comparison of CYP2C9 and CYP2C18 promoter regions

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900076-5

7 January 2021

Characterization of cDNAs, mRNAs, and proteins related to human liver microsomal cytochrome P-450 (S)-mephenytoin 4'-hydroxylase

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900076-5

7 January 2021

Rapid detection of CYP2C9*3 alleles by real-time fluorescence PCR based on SYBR Green

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900076-5

7 January 2021

Cytochrome P4502C9 (CYP2C9) allele frequencies in Canadian Native Indian and Inuit populations

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900076-5

7 January 2021

Polymorphism of the cytochrome P450 (CYP) 2C9 gene in Japanese epileptic patients: genetic analysis of the CYP2C9 locus

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900076-5

7 January 2021

Relationship of polymorphism in CYP2C9 to genetic susceptibility to diclofenac-induced hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900076-5

7 January 2021

Catalytic activity of three variants (Ile, Leu, and Thr) at amino acid residue 359 in human CYP2C9 gene and simultaneous detection using single-strand conformation polymorphism analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900076-5

7 January 2021

Identification of a null allele of CYP2C9 in an African-American exhibiting toxicity to phenytoin

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900076-5

7 January 2021

Genetic polymorphism in exon 4 of cytochrome P450 CYP2C9 may be associated with warfarin sensitivity in Chinese patients

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900076-5

7 January 2021

Genetic analysis of CYP2C9 polymorphism in a Japanese population

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900076-5

7 January 2021

Frequency of cytochrome P450 CYP2C9 variants in a Turkish population and functional relevance for phenytoin

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900076-5

7 January 2021

Association analysis of drug metabolizing enzyme gene polymorphisms in HIV-positive patients with co-trimoxazole hypersensitivity

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900076-5

7 January 2021

Frequency of cytochrome P450 2C9 mutant alleles in a Korean population

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900076-5

7 January 2021

Validation of methods for CYP2C9 genotyping: frequencies of mutant alleles in a Swedish population.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900076-5

7 January 2021

CYP2C9 polymorphism and warfarin dose requirements

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900076-5

7 January 2021

CYP2C9 polymorphisms and CYP2C9*2 genotyping primers

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900076-5

7 January 2021

Allelic variants of human cytochrome P450 2C9: baculovirus-mediated expression, purification, structural characterization, substrate stereoselectivity, and prochiral selectivity of the wild-type and I359L mutant forms.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900076-5

7 January 2021

The R144C change in the CYP2C9*2 allele alters interaction of the cytochrome P450 with NADPH:cytochrome P450 oxidoreductase

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900076-5

7 January 2021

CYP2C9 Ile359 and Leu359 variants: enzyme kinetic study with seven substrates

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900076-5

7 January 2021

Comparative studies on the catalytic roles of cytochrome P450 2C9 and its Cys- and Leu-variants in the oxidation of warfarin, flurbiprofen, and diclofenac by human liver microsomes

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900076-5

7 January 2021

A common genetic basis for idiosyncratic toxicity of warfarin and phenytoin.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900076-5

7 January 2021

Comparisons between in-vitro and in-vivo metabolism of (S)-warfarin: catalytic activities of cDNA-expressed CYP2C9, its Leu359 variant and their mixture versus unbound clearance in patients with the corresponding CYP2C9 genotypes

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900076-5

7 January 2021

Genetic association between sensitivity to warfarin and expression of CYP2C9*3

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900076-5

7 January 2021

CYP2C9*3 allelic variant and bleeding complications

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900076-5

7 January 2021

Extreme warfarin sensitivity in siblings associated with multiple cytochrome P450 polymorphisms

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900076-5

7 January 2021

The possession of the CYP2C9*3 allele is associated with low dose requirement of acenocoumarol

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900076-5

7 January 2021

Early acenocoumarol overanticoagulation among cytochrome P450 2C9 poor metabolizers

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900076-5

7 January 2021

Phenotypic and genotypic investigations of a healthy volunteer deficient in the conversion of losartan to its active metabolite E-3174

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900076-5

7 January 2021

Pharmacokinetics of losartan and its metabolite E-3174 in relation to the CYP2C9 genotype

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900076-5

7 January 2021

Pharmacokinetics of chlorpheniramine, phenytoin, glipizide and nifedipine in an individual homozygous for the CYP2C9*3 allele

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900076-5

7 January 2021

Association between CYP2C9 genetic variants and anticoagulation-related outcomes during warfarin therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900076-5

7 January 2021

Association of polymorphisms in the cytochrome P450 CYP2C9 with warfarin dose requirement and risk of bleeding complications

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900076-5

7 January 2021

Pharmacogenetics of warfarin elimination and its clinical implications

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900076-5

7 January 2021

Genetic polymorphism of the CYP2C subfamily and its effect on the pharmacokinetics of phenytoin in Japanese patients with epilepsy

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900076-5

7 January 2021

Genetic polymorphism of cytochrome P450s, CYP2C19, and CYP2C9 in a Japanese population.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900076-5

7 January 2021

The effects of genetic polymorphisms of CYP2C9 and CYP2C19 on phenytoin metabolism in Japanese adult patients with epilepsy: studies in stereoselective hydroxylation and population pharmacokinetics

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900076-5

7 January 2021

Lung cancer risk in relation to the CYP2C9*1/CYP2C9*2 genetic polymorphism among African-Americans and Caucasians in Los Angeles County, California

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900076-5

7 January 2021

Genetic polymorphism of cytochrome P450 2C9 in a Caucasian and a black African population.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900076-5

7 January 2021

Lung cancer risk in relation to the CYP2C9 genetic polymorphism among Caucasians in Los Angeles County

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900076-5

7 January 2021

The effect of genetic polymorphism of cytochrome P450 CYP2C9 on phenytoin dose requirement

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900076-5

7 January 2021

Is diclofenac a valuable CYP2C9 probe in humans?

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900076-5

7 January 2021

Analyses of bronchial bulky DNA adduct levels and CYP2C9, GSTP1 and NQO1 genotypes in a Hungarian study population with pulmonary diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900076-5

7 January 2021

High frequency of mutations related to impaired CYP2C9 metabolism in a Caucasian population

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900076-5

7 January 2021

Factors determining the maintenance dose of warfarin in Chinese patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900076-5

7 January 2021

Human P450 metabolism of warfarin

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900076-5

7 January 2021

Cytochrome P450 polymorphisms are associated with reduced warfarin dose

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900076-5

7 January 2021

Metabolism of warfarin enantiomers in Japanese patients with heart disease having different CYP2C9 and CYP2C19 genotypes.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900076-5

7 January 2021

Population differences in S-warfarin metabolism between CYP2C9 genotype-matched Caucasian and Japanese patients

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900076-5

7 January 2021

Individual sulfonylureas and serious hypoglycemia in older people.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900076-5

7 January 2021

Major bleeding after hospitalization for deep-venous thrombosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900076-5

7 January 2021

Racial background is a determinant of average warfarin dose required to maintain the INR between 2.0 and 3.0.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900076-5

7 January 2021